Wednesday, September 28, 2022
ADVT 
Health

Surgery backlog could take 84 weeks to clear: study

Darpan News Desk The Canadian Press, 01 Sep, 2020 07:32 PM
  • Surgery backlog could take 84 weeks to clear: study

A new study suggests it could take more than a year and a half to clear the backlog of surgeries in Ontario hospitals caused by the COVID-19 pandemic.

Modelling research published today in the Canadian Medical Association Journal says the estimated time to clear surgeries postponed due to the pandemic is 84 weeks, with a target of 717 surgeries per week.

The provincial government instructed Ontario hospitals to cancel elective surgeries and other activities deemed not urgent in mid-March to prepare for a possible surge of COVID-19 patients.

That directive was lifted in late May and hospitals gradually resumed performing those surgeries.

The study says that between March 15 and June 13, Ontario hospitals accrued a backlog of 148,364 procedures.

Its authors say the data will play an important role in health planning moving forward, and the modelling framework can be adapted to other jurisdictions.

"The magnitude of the surgical backlog from COVID-19 raises important implications for planning for the recovery phase and for possible second waves of the pandemic in Ontario," study co-author Dr. Jonathan Irish, a surgeon at Princess Margaret Cancer Centre in Toronto, said in a statement.

The researchers say health systems "cannot go back to business as usual" if they want to manage the impact on patients, and must find innovative solutions to prepare for future waves of the novel coronavirus.

MORE Health ARTICLES

Trail of bubbles leads scientists to new coronavirus clue

Trail of bubbles leads scientists to new coronavirus clue

A doctor checking comatose COVID-19 patients for signs of a stroke instead stumbled onto a new clue about how the virus may harm the lungs -- thanks to a test that used tiny air bubbles and a robot.

Trail of bubbles leads scientists to new coronavirus clue

FDA blocks much-anticipated BioMarin hemophilia gene therapy

FDA blocks much-anticipated BioMarin hemophilia gene therapy

Investors fled drug developer BioMarin in droves on Wednesday, driving shares down by a third after U.S. regulators rejected the company’s potentially game-changing hemophilia A gene therapy over concerns it might not really be a one-and-done lifetime treatment.

FDA blocks much-anticipated BioMarin hemophilia gene therapy

Many steps needed for accurate COVID-19 test results

Many steps needed for accurate COVID-19 test results

A widely used coronavirus test is under scrutiny this week after federal health officials warned that it could deliver inaccurate results if laboratory technicians don't follow the the latest updates from the manufacturer.

Many steps needed for accurate COVID-19 test results

Has the coronavirus mutated in any significant way?

Has the coronavirus mutated in any significant way?

Has the coronavirus mutated in any significant way?

Has the coronavirus mutated in any significant way?

Study hints, can't prove, survivor plasma fights COVID-19

Study hints, can't prove, survivor plasma fights COVID-19

Mayo Clinic researchers reported a strong hint that blood plasma from COVID-19 survivors helps other patients recover, but it’s not proof and some experts worry if, amid clamour for the treatment, they'll ever get a clear answer.

Study hints, can't prove, survivor plasma fights COVID-19

Kids harmed by edible pot: Health Canada

Kids harmed by edible pot: Health Canada

Health Canada is warning people to do more to keep edible pot products out of the hands of kids.

Kids harmed by edible pot: Health Canada